Cytori Therapeutics Announces Participation in the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum

SAN DIEGO, CA--(Marketwire - Nov 28, 2011) - Cytori Therapeutics (NASDAQ: CYTX) will present at the 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum on December 1. In addition, CEO Christopher Calhoun will participate on a regenerative medicine business panel also on December 1.

Cytori's presentation and panel participation will be video-recorded and posted to the Company's website subsequent to the event.

The following are specific details regarding Cytori's participation at the conference:

Cytori Company Presentation
Date: December 1, 2011
Time: 11:57 AM PT

Panel: Developing Sustainable and Scalable Business Models in Regenerative Medicine
Date: December 1, 2011
Time: 3:15 PM PT

The Investor and Partnering Forum will take place at the Sanford Consortium for Regenerative Medicine Building in La Jolla, California. Please see the full conference agenda here: http://stemcellmeetingonthemesa.com/investor-and-partnering-forum/agenda/.

About the Stem Cell Meeting on the Mesa's Investor and Partnering Forum:

The Investor and Partnering Forum is being organized by the Sanford Consortium, CIRM and The Alliance for Regenerative Medicine (ARM) to facilitate translational research, promote engagement between the scientific and business communities and provide opportunities for business, academic research and investor participants to connect in one-on-one strategic partnering meetings. To learn more or to register for the 2011 Stem Cell Meeting on the Mesa Symposium and Investor & Partnering Forum, please visit www.stemcellmeetingonthemesa.com.

About Cytori

Cytori is a leader in cell therapy, providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft® products are available in North America and Europe for fat grafting procedures. www.cytori.com